Dec 18, 2025
2 0
Canary Capital Files for Staked Injective ETF With U.S. SEC
Canary Capital has filed with the U.S. SEC to launch a staked Injective ETF, providing regulated exposure to INJ cryptocurrency and offering staking rewards.
Key Details of Canary's Injective ETF Proposal
- The ETF would be listed on Cboe, offering investors access to INJ spot prices.
- Staking rewards are included, but specific partners for staking are yet to be announced.
- U.S. Bancorp Fund Services is set as the transfer agent and cash custodian, while BitGo Trust Company will be the digital asset custodian.
- The ETF tracks performance based on the INJ-USD CCIXber Reference Rate price index.
- Shares will be created and redeemed in blocks of 10,000.
- Paralel Distributors LLC is named as the marketing agent.
Growth in the Injective Ecosystem
- Injective ecosystem transactions surged from 0-1,000 weekly in 2023 to nearly 1 million.
- Activities include decentralized exchanges, minting, staking, derivatives, swaps, NFT interactions, and real-world asset tokenization.
- Injective advances RWA adoption; a $10 billion mortgage portfolio is being brought on-chain via Injective.
Current Market Situation for INJ
- INJ price is down 5.6% at $4.58, below key moving averages, indicating short-term weakness.
- RSI at 30.67 suggests oversold conditions, hinting at a potential short-term technical rebound.
- Trading volume needs to increase for a sustained recovery, with potential entry near $4.50 and target around $5.50.
